Spectroscopic study of the interaction of coumarin anticoagulant drugs with polyvinylpyrrolidone. 1989

M Otagiri, and T Imai, and H Koinuma, and U Matsumoto
Faculty of Pharmaceutical Sciences, Kumamoto University, Japan.

The interaction of coumarin anticoagulants with polyvinylpyrrolidone (PVP) was investigated using a fluorescence technique. The fluorescence intensities of warfarin and phenprocoumon were greatly enhanced following binding to PVP, while the fluorescence of 4-hydroxycoumarin was little enhanced in the presence of PVP. The enhanced fluorescence of warfarin and phenprocoumon bound to PVP can be explained by their incorporation into the hydrophobic environment in the PVP and by a decrease in the internal rotation of the alpha-substituted benzyl group in the drugs. The binding parameters of warfarin and phenprocoumon were estimated by the Klotz method; the binding constants for phenprocoumon and warfarin were found to be 2.6 X 10(4) and 2.2 X 10(4) M-1, respectively. The 13C-NMR measurements suggest the lactone moiety in the 4-hydroxycoumarin and the substituted benzene ring play an important role in the binding to PVP.

UI MeSH Term Description Entries
D010644 Phenprocoumon Coumarin derivative that acts as a long acting oral anticoagulant. Phenprocoumalol,Phenprocoumarol,Phenylpropylhydroxycumarinum,Falithrom,Liquamar,Marcoumar,Marcumar,Phenprogramma
D011205 Povidone A polyvinyl polymer of variable molecular weight; used as suspending and dispersing agent and vehicle for pharmaceuticals; also used as blood volume expander. Polvidone,Polyvidon,Polyvinylpyrrolidone,Arufil,Bolinan,Bolinan 40,Crospovidone,Dulcilarmes,Duratears Free,Enterodes,Enterodez,Hypotears,Kollidon,Lacophtal,Lacri-Stulln,Lagrifilm,Liquifilm Lagrimas,Nutrivisc,Oculotect,PVP 40,Periston,Plasdone,Polyplasdone XL,Povidone, Unspecified,Protagens,Protagent,Unifluid,Vidirakt S mit PVP,Vidisic PVP Ophtiole,Wet-Comod,Dulcilarme,Enterode,Hypotear,Polyvidons,Protagen,Unspecified Povidone
D003374 Coumarins Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. 1,2-Benzopyrone Derivatives,1,2-Benzopyrones,Coumarin Derivative,Coumarine,1,2-Benzo-Pyrones,Benzopyran-2-ones,Coumarin Derivatives,Coumarines,1,2 Benzo Pyrones,1,2 Benzopyrone Derivatives,1,2 Benzopyrones,Benzopyran 2 ones,Derivative, Coumarin,Derivatives, 1,2-Benzopyrone,Derivatives, Coumarin
D013050 Spectrometry, Fluorescence Measurement of the intensity and quality of fluorescence. Fluorescence Spectrophotometry,Fluorescence Spectroscopy,Spectrofluorometry,Fluorescence Spectrometry,Spectrophotometry, Fluorescence,Spectroscopy, Fluorescence
D014859 Warfarin An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one,Aldocumar,Apo-Warfarin,Coumadin,Coumadine,Gen-Warfarin,Marevan,Tedicumar,Warfant,Warfarin Potassium,Warfarin Sodium,Potassium, Warfarin,Sodium, Warfarin
D015110 4-Hydroxycoumarins Substances found in many plants, containing the 4-hydroxycoumarin radical. They interfere with vitamin K and the blood clotting mechanism, are tightly protein-bound, inhibit mitochondrial and microsomal enzymes, and are used as oral anticoagulants. 4 Hydroxycoumarins
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

M Otagiri, and T Imai, and H Koinuma, and U Matsumoto
January 1955, British medical bulletin,
M Otagiri, and T Imai, and H Koinuma, and U Matsumoto
May 1966, Annals of internal medicine,
M Otagiri, and T Imai, and H Koinuma, and U Matsumoto
April 1967, California medicine,
M Otagiri, and T Imai, and H Koinuma, and U Matsumoto
May 1967, The Journal of clinical investigation,
M Otagiri, and T Imai, and H Koinuma, and U Matsumoto
July 1968, Annals of the New York Academy of Sciences,
M Otagiri, and T Imai, and H Koinuma, and U Matsumoto
January 1966, Thrombosis et diathesis haemorrhagica. Supplementum,
M Otagiri, and T Imai, and H Koinuma, and U Matsumoto
January 1965, Federation proceedings,
M Otagiri, and T Imai, and H Koinuma, and U Matsumoto
December 1962, American heart journal,
M Otagiri, and T Imai, and H Koinuma, and U Matsumoto
September 2012, Cancer biotherapy & radiopharmaceuticals,
M Otagiri, and T Imai, and H Koinuma, and U Matsumoto
September 2008, Journal of thrombosis and haemostasis : JTH,
Copied contents to your clipboard!